Rovin Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,741
| Closed | -$635K | – | 171 |
|
|
2024
Q2 | $635K | Buy |
2,741
+361
| +15% | +$83.6K | 0.26% | 76 |
|
|
2024
Q1 | $513K | Buy |
2,380
+318
| +15% | +$68.5K | 0.21% | 93 |
|
|
2023
Q4 | $534K | Buy |
2,062
+480
| +30% | +$124K | 0.24% | 79 |
|
|
2023
Q3 | $407K | Sell |
1,582
-165
| -9% | -$42.4K | 0.19% | 80 |
|
|
2023
Q2 | $498K | Sell |
1,747
-149
| -8% | -$42.5K | 0.22% | 72 |
|
|
2023
Q1 | $527K | Sell |
1,896
-537
| -22% | -$149K | 0.25% | 63 |
|
|
2022
Q4 | $674K | Sell |
2,433
-145
| -6% | -$40.2K | 0.34% | 52 |
|
|
2022
Q3 | $688K | Sell |
2,578
-53
| -2% | -$14.1K | 0.39% | 43 |
|
|
2022
Q2 | $537K | Buy |
2,631
+81
| +3% | +$16.5K | 0.36% | 54 |
|
|
2022
Q1 | $537K | Buy |
2,550
+819
| +47% | +$172K | 0.29% | 59 |
|
|
2021
Q4 | $415K | Buy |
+1,731
| New | +$415K | 0.2% | 81 |
|